Zolpidem oral spray (ZolpiMist) compared with zolpidem tablet formulation in elderly volunteers.

Trial Profile

Zolpidem oral spray (ZolpiMist) compared with zolpidem tablet formulation in elderly volunteers.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Feb 2011

At a glance

  • Drugs Zolpidem (Primary)
  • Indications Insomnia
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors NovaDel Pharma
  • Most Recent Events

    • 05 Feb 2011 Zolpimist Oral Spray launched in the US, according to a NovaDel media release.
    • 05 Feb 2011 ECR Pharmaceuticals Co., a subsidiary of Hi-Tech Pharmacal Co., announced the immediate availability of Zolpimist Oral Spray n the US, in a media release.
    • 24 Jan 2008 Status change from initiated to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top